Pallando Therapeutics
PrivateLast Round
Seed
Jun 24, 2025
Total Funding Raised
$8M
Company Overview
Pallando Therapeutics is a biotechnology company that provides precision targeting services intended to transform the oncology treatment landscape.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pallando Therapeutics Comparables
Compare Pallando Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TenSixty Bio | 81% | |
| Bayer AG | 73% | |
| TRIANA Biomedicines | 71% |
Pallando Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jun 24, 2025 |
Pallando Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| General Catalyst | Seed |
| BVF Partners L.P. | Seed |
| Astellas Venture Management | Seed |
| 8VC | Seed |
Pallando Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Pallando Therapeutics's valuation, stock price, and market status.
Is Pallando Therapeutics a public or private company?
Pallando Therapeutics is a private company.
What is the current stock price of Pallando Therapeutics?
Pallando Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Pallando Therapeutics worth (valuation)?
Valuation information for Pallando Therapeutics is not publicly available.
Can I buy Pallando Therapeutics stock?
Pallando Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Pallando Therapeutics's last funding round?
Pallando Therapeutics's most recent funding round was Seed on June 24, 2025.
Who are the main investors in Pallando Therapeutics?
Key investors in Pallando Therapeutics include General Catalyst, BVF Partners L.P., Astellas Venture Management, 8VC.
Will Pallando Therapeutics IPO soon?
No public IPO plans have been announced for Pallando Therapeutics.
How can I track Pallando Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Pallando Therapeutics's secondary market activity and sign up for updates.